WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 9'3701 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 19'4011 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 19'511  19'652  19'794  19'945  20'112  22'128  23'489  22'612 
Births 179  182  186  191  196  222  318  399 
Surviving infants 177  181  185  189  194  218  310  388 
Pop. less than 5 years 924  952  988  1'026  1'050  1'120  1'785  2'050 
Pop. less than 15 years 3'028  3'061  3'103  3'148  3'186  4'101  5'578  6'059 
Female 15-49 years 4'541  4'604  4'648  4'685  4'732  5'624  5'627  5'436 

Number of reported cases

(Click for retrospective incidence data for Romania)
Diphtheria
ChartChart
  12 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  59  1'159  7'450  4'189  35  4'691  10'476 
Mumps
ChartChart
  446  107  98  163  195  26'542 
Pertussis
ChartChart
  93  87  57  82  86  493  817  11'441 
Polio*
ChartChart
  125 
Rubella
ChartChart
  30  145  20'812  3'494  5'125 
Rubella (CRS)
ChartChart
  26  45  55  20 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  20  14  33  33 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Romania)
Vaccine year result method % card seen                                                
BCG          98  98  99  99  99  99*  90 
DTP1         
DTP3          89  94  99  96 
DTP4         
IPV1         
HepB_BD          96  73  98  99  99*  99* 
HepB3          90  94  96  96  96  98 
Hib3          92  89 
JapEnc         
MCV1          86  89  92  94  93  98  92 
MCV2          88  91  97 
PCV1         
PCV3         
Pol3          89  94  88  92  89  99  92 
Rota1         
RotaC         
Rubella1          86  92  94 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Romania)
BCG
ChartChart
  98  98  99  99  99  90 
DTP1
ChartChart
  98  97  97  96  99  98 
DTP3
ChartChart
  94  92  91  89  99  96 
HepB3
ChartChart
  94  96  96  96  98 
HepB_BD
ChartChart
  73  98  99  99  99 
Hib3
ChartChart
  92  92  92  89 
MCV1
ChartChart
  89  92  94  93  98  92 
MCV2
ChartChart
  88  88  90  91  96 
PCV3
ChartChart
 
Pol3
ChartChart
  94  88  92  89  99  92 
RotaC
ChartChart
 

Number of districts in the country 42  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 45
From 50 to 79% 12
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 4, 11 months; Yes
DTaPIPV 6 years; Yes
HPV No private sector
HepB birth; Yes
IPV 6, 8 years; Yes
Influenza_Adult Yes elderly, pregnant women, health care workers, adults with chronic diseases and other risk group
Influenza_Pediatric Yes children with chronic diseases
MMR 12 months; 5-7 years; Yes
MenAC No travelers
Rotavirus No private sector
Td 14 years; Yes
Typhoid No travelers
Varicella No private sector
YF No travelers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 42  42  42  42  42  42  42 

System performance

Total Nº districts in country number 42  42  42  42  42  42  42 
Nº districts with DTP3 coverage >=80% number 42  36  41  38    42  42 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  86  98  90    100  100 
Nº districts with measles (MCV1) coverage >=95% number 12  22  19    34  34 
% of districts with MCV1 coverage >=95% From 0 to 100% 14  29  52  45    81  81 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100        100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.